Concepedia

Author

Vito Sansone

University of BolognaORCID

Also Known As

Sansone, V., V J Sansone, V Sansone, V. Sansone, V.J. Sansone, Vito Sansone

46

Publications

482

Citations

11

H-Index

15

Concepts

All Affiliations

University of BolognaAzienda USL di BolognaUniversity of FoggiaIstituti di Ricovero e Cura a Carattere ScientificoAzienda Ospedaliera Universitaria Pisana
VS

About

Vito Sansone is an author at University of Bologna specializing in medicine, rheumatoid arthritis, and allergy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

96

2

Allergy

1

1

32

3

Gastroenterology

1

1

64

4

Pharmacology

1

1

32

5

Chronic Inflammation

1

1

32

Vito Sansone

×

9

Publications

203

Citations

9

H-Index

YearCitations

Factors That Affect Adequacy of Colon Cleansing for Colonoscopy in Hospitalized Patients

Lorenzo Fuccio, Leonardo Frazzoni, Cristiano Spada,

Clinical Gastroenterology and Hepatology

2020

64

Interaction of aspirin with nonsteroidal anti-inflammatory drugs in rats

Z.E. Mielens, Hans P. Drobeck, J. JUN. ROZITIS,

Journal of Pharmacy and Pharmacology

1968

32

Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib

Vito Sansone, Francesco Tovoli, Andrea Casadei‐Gardini,

Clinical and Translational Gastroenterology

2021

21

Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders

Luca Ielasi, Francesco Tovoli, Matteo Tonnini,

Cancers

2021

20

Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment

Filippo Pelizzaro, Selion Haxhi, Barbara Penzo,

Frontiers in Oncology

2022

19

Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis

Francesco Tovoli, Giulia Negrini, Vito Sansone,

Nutrients

2018

13

Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib

Margherita Rimini, Changoon Yoo, Sara Lonardi,

Hepatology Research

2021

13

Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments

Francesco Tovoli, Dante Pio Pallotta, Vito Sansone,

Transplantation

2022

11

Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment

Alessandro Cucchetti, Annagiulia Gramenzi, Philip J. Johnson,

European Journal of Cancer

2021

10

Page 1